Alterations in striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned macaque model of Parkinson's disease

被引:0
|
作者
Hallett, PJ
Dunah, AW
Crossman, AR
Brotchie, JM
Standaert, DG
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P531
引用
收藏
页码:S189 / S190
页数:2
相关论文
共 50 条
  • [1] Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
    Hallett, PJ
    Dunah, AW
    Ravenscroft, P
    Zhou, S
    Bezard, E
    Crossman, AR
    Brotchie, JM
    Standaert, DG
    NEUROPHARMACOLOGY, 2005, 48 (04) : 503 - 516
  • [2] Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesia
    Silverdale, MA
    Crossman, AR
    Brotchie, JM
    EXPERIMENTAL NEUROLOGY, 2002, 174 (01) : 21 - 28
  • [3] L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease
    Huot, Philippe
    Johnston, Tom H.
    Koprich, James B.
    Fox, Susan H.
    Brotchie, Jonathan M.
    NEUROPHARMACOLOGY, 2012, 63 (05) : 829 - 836
  • [4] COMT inhibition as an approach to minimising L-DOPA-induced dyskinesia in the MPTP-lesioned macaque model of Parkinson's disease
    Johnston, T. H.
    Huot, P.
    Koprich, J. B.
    Snoeren, T.
    Hill, M. P.
    Fox, S. H.
    Brotchie, J. M.
    MOVEMENT DISORDERS, 2013, 28 : S358 - S359
  • [5] μ- and δ-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
    Henry, B
    Fox, SH
    Crossman, AR
    Brotchie, JM
    EXPERIMENTAL NEUROLOGY, 2001, 171 (01) : 139 - 146
  • [6] Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of parkinson’s disease
    Wassilios Meissner
    Caroline Prunier
    Denis Guilloteau
    Sylvie Chalon
    Christian E. Gross
    Erwan Bezard
    Molecular Neurobiology, 2003, 28 : 209 - 218
  • [7] Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease
    Silverdale, MA
    Nicholson, SL
    Crossman, AR
    Brotchie, JM
    MOVEMENT DISORDERS, 2005, 20 (04) : 403 - 409
  • [8] Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease
    Meissner, W
    Prunier, C
    Guilloteau, D
    Chalon, S
    Gross, CE
    Bezard, E
    MOLECULAR NEUROBIOLOGY, 2003, 28 (03) : 209 - 218
  • [9] Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease
    Bassilana, F
    Mace, N
    Li, Q
    Stutzmann, JM
    Gross, CE
    Pradier, L
    Benavides, J
    Ménager, J
    Bezard, E
    NEUROBIOLOGY OF DISEASE, 2005, 20 (01) : 93 - 103
  • [10] Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease
    Nash, JE
    Fox, SH
    Henry, B
    Hill, MP
    Peggs, D
    McGuire, S
    Maneuf, Y
    Hille, C
    Brotchie, JM
    Crossman, AR
    EXPERIMENTAL NEUROLOGY, 2000, 165 (01) : 136 - 142